|
(MoneyNewsWire.Net, July 10, 2017 ) South Korea’s rapid economic growth has nurtured the development of a robust healthcare sector in a short period. Its pharmaceutical market is ranked 13th in the world, in terms of revenue generated and the third largest in Asia. Considering the current scenario, South Korea Over the Counter (OTC) Drugs market is estimated at USD 4.1 billion in 2016 and is predicted to reach USD 5.78 billion by 2021, growing at a CAGR of 7.11%.
Browse market data tables and in-depth TOC of the South Korea Over the Counter (OTC) Drugs Market to 2021 @ http://www.marketdataforecast.com/market-reports/south-korea-over-the-counter-drugs-market-802/
An increase in employment of self-medication is observed in recent times due to the growing awareness on various health conditions and treatments. This is propelling the market growth for OTC drugs. Further, increasing numbers of geriatric population is one of the factor driving the growth of South Korea OTC drug market. As increasing age is associated with prevalence of chronic medical conditions, a higher number of medicines are used, leading to higher demand for all medical services, including alternative services like self-medication etc.
Similar to the global scenario, rising issues of substance abuse has forced stringent regulations for the use of certain categories of drugs, effecting the South Korea OTC Drugs market. Further, under South Korea’s Pharmaceutical Law, only pharmacies have exclusive rights to manage pharmaceutical products, including OTC drugs. This has been limiting the reach of various products to consumers, which acts as a hurdle for market growth. Anyways, the Korea’s Ministry of Health and Welfare has initiated negotiations between groups representing pharmacists, doctors, consumers, and the government to ease these restrictions on sales of over-the-counter (OTC) drugs.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/south-korea-over-the-counter-drugs-market-802/request-sample
The South Korea’s OTC drug’s market is segmented on the basis of product type into Cough, Cold and Flu Drugs, Analgesics, Dermatologics, Gastrointestinal Drugs, Antiseptics, Anti-Allergy Drugs, Smoking Cessation Aids, Ophthalmics, Vitamins and Minerals, Sleep Aids, Weight Loss/Diet Drugs and Others (Ear Drops & Diuretics). And on the basis of formulation, the market is analysed under Liquids, Ointments, Tablets and Sprays.
Further, based on distribution channel the OTC drugs market is segmented into Pharmacies, Supermarkets/Hypermarkets and Convenience stores. As stated earlier, most of the OTC drugs in South Korea are distributed through Pharmacies. But with the efforts by government to ease the regulations, sales through supermarkets and convenience stores are expected to pick up in the coming few years.
Some of the major companies offering OTC drugs in South Korea are GlaxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, Sanofi, Takeda Pharmaceuticals, Boehringer Ingelheim, Yuhan Corporation, Hanmi Pharmaceuticals, Dong Wha Pharmaceuticals.
Avail discount @ http://www.marketdataforecast.com/market-reports/south-korea-over-the-counter-drugs-market-802/request-discount
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
